Planet 13 Holdings (PLNH) Net Income towards Common Stockholders (2021 - 2026)

Planet 13 Holdings (PLNH) reported Net Income towards Common Stockholders of -$8.1 million for Q1 2026, down 295.46% year-over-year from $4.1 million in Q1 2025, and down 232.19% quarter-over-quarter from $6.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$8.1 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$8.1 million, down 295.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$59.2 million (down 34.7% YoY), and the FY2025 annual result was -$53.2 million, down 11.26% from the prior year.
  • Net Income towards Common Stockholders slipped to -$8.1 million in Q1 2026 per PLNH's latest filing, from $6.1 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $6.1 million in Q4 2025 and troughed at -$46.3 million in Q3 2023.
  • A 5-year average of -$14.2 million and a median of -$8.1 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 2131.73% in 2022, then jumped 123.16% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$42.1 million in 2022, then jumped by 66.13% to -$14.3 million in 2023, then sank by 85.43% to -$26.4 million in 2024, then jumped by 123.16% to $6.1 million in 2025, then slumped by 232.19% to -$8.1 million in 2026.
  • Business Quant data shows PLNH's Net Income towards Common Stockholders at -$8.1 million in Q1 2026, $6.1 million in Q4 2025, and -$44.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Planet 13 Holdings - - 9.41 Mn -8.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.10 Mn
Dec 31, 2025 6.12 Mn
Sep 30, 2025 -43.96 Mn
Jun 30, 2025 -13.30 Mn
Mar 31, 2025 -2.05 Mn
Dec 31, 2024 -26.44 Mn
Sep 30, 2024 -7.41 Mn
Jun 30, 2024 -8.07 Mn
Mar 31, 2024 -5.87 Mn
Dec 31, 2023 -14.26 Mn
Sep 30, 2023 -46.25 Mn
Jun 30, 2023 -4.62 Mn
Mar 31, 2023 -8.48 Mn
Dec 31, 2022 -42.09 Mn
Sep 30, 2022 -6.32 Mn
Jun 30, 2022 -7.07 Mn
Mar 31, 2022 -4.06 Mn
Dec 31, 2021 -27.41 Mn
Sep 30, 2021 4.05 Mn
Jun 30, 2021 347,962.00